Financials data is unavailable for this security.
View more
Year on year Mesoblast Ltd 's revenues fell -21.32% from 7.50m to 5.90m. a loss of 81.89m to a larger loss of 87.96m.
Gross margin | -166.30% |
---|---|
Net profit margin | -1,490.28% |
Operating margin | -1,173.11% |
Return on assets | -13.14% |
---|---|
Return on equity | -17.91% |
Return on investment | -14.38% |
More ▼
Cash flow in USDView more
In 2024, cash reserves at Mesoblast Ltd fell by 8.36m. Cash Flow from Financing totalled 40.25m or 682.01% of revenues. In addition the company used 48.46m for operations while cash used for investing totalled 97.00k.
Cash flow per share | -0.1264 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6303 |
---|---|
Tangible book value per share | -0.1252 |
More ▼
Balance sheet in USDView more
Current ratio | 1.18 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.2476 |
---|---|
Total debt/total capital | 0.1984 |
More ▼